Genego’s ToxHunter™ Suite of Tools and Content for Systems Toxicology Research Now Available
July 13, 2010
St. Joseph, Michigan – GeneGo announced the availability of ToxHunter™, the first commercial release of tools and content developed through its industry-FDA MetaTox™ partnership program, a collaborative program developing a unique comprehensive systems toxicology suite designed for compound safety assessment in chemical and pharmaceutical R&D. ToxHunter is now available as an add-on to existing licenses [...]
Asuragen and Life Technologies Launch CE-Marked BCR/ABL1 Quant™ Leukemia Test in Europe
July 13, 2010
AUSTIN, Tex and CARLSBAD, Calif. - Asuragen, Inc. and Life Technologies Corporation (NASDAQ: LIFE) announced today that they have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 Quant™ Test, Asuragen’s clinically validated and cGMP manufactured test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML). [...]
Meridian Bioscience Receives FDA Clearance for New illumigene(TM) Molecular Platform
July 13, 2010
CINCINNATI - Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its new molecular amplification assay, illumigene(TM) C.difficile. Clostridium difficile is a bacterium that can cause diarrhea and, in severe cases, a life-threatening inflammation of the colon. The illumigene molecular amplification assay [...]
InQ Biosciences Introduces First Fully Integrated Cellular Research System
July 13, 2010
HUNTSVILLE, ALABAMA, U.S.A. - InQ Biosciences, a provider of innovative technologies for cell growth and research, announced its plans to launch the InQTM Cell Research System during the fourth quarter of 2010. InQ is the first fully integrated system that creates a high fidelity in vivo environment for studying stem cells, plus nerve, brain, and [...]
July 12, 2010
SOUTH EASTON, Mass. - Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" and the "Company") today announced that Mr. Alan I. Goldberg has been unanimously elected to fill the open, Class III seat on the Company's Board of Directors, effective Monday, July 12, 2010. This seat has been vacant since shareholders voted to amend the Company's Articles of [...]
Biochrom Announced Sam Luke as the New Group Managing Director
July 12, 2010
Cambridge, UK: Biochrom Ltd the UK based subsidiary of Harvard Bioscience Inc. (Nasdaq:HBIO), has announced the appointment of Sam Luke as its new Group Managing Director. He takes the helm of a company with rapidly expanding future potential and a 40 year history of designing and manufacturing high quality scientific instrumentation for the Analytical and [...]
Dolomite Introduces Pressure-based Droplet Generation System
July 12, 2010
Providing rapid advances in micro-droplet research Royston, UK - Dolomite, a world leader in microfluidic design and manufacture, has introduced the Pressure-based Droplet Starter System, which is ideal for the initial exploration of droplet microfluidics. It provides a complete solution containing all necessary pumps, connectors and chips, enabling the immediate production of highly monodispersed droplets [...]
SDIX to Help Egg Producers Meet New FDA Regulatory
July 12, 2010
Challenge Easy Use, Cost-Effective RapidChek® SELECT™ Salmonella Enteritidis Designed Specifically For New FDA Regulation NEWARK, DE – SDIX™ (Strategic Diagnostics Inc., d/b/a SDIX, Nasdaq: SDIX), a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic, and food safety applications, today commercially launched the RapidChek® SELECT™ Salmonella Enteritidis testing [...]
Accuri Cytometers Completes $6 Million Series E Financing
July 12, 2010
Ann Arbor, MI - Accuri Cytometers, Inc., a world leader in providing life science researchers with easy-to-use, cost-effective flow cytometers, today announced completion of a $6 million Series E preferred stock financing. The financing included current investors Arboretum Ventures, Baird Venture Partners, Fidelity Biosciences, Flagship Ventures and the InvestMichigan! Program co-managed by Credit Suisse. Accuri [...]
IDT Signs Contract to Supply Research Councils UK with Custom Oligonucleotides
July 12, 2010
Three year deal to advance UK scientific research CORALVILLE, IA – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, has signed a three year contract with Research Councils UK (RCUK) for the supply of synthetic oligonucleotides. RCUK coordinates the UK’s seven research councils, enhancing the overall impact and effectiveness of the research they [...]

